Access to a 750 mcg Teriparatide formulation within Australia is limited. Although it is approved for use in treating osteoporosis, sales of this particular formulation are significantly restricted . Physicians could need to seek specific approval through a appropriate pathway secure it for their patients . It's important note that local get more i